209 related articles for article (PubMed ID: 27893432)
1. MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma.
Xiang ZL; Zhao XM; Zhang L; Yang P; Fan J; Tang ZY; Zeng ZC
Oncotarget; 2016 Dec; 7(52):87246-87256. PubMed ID: 27893432
[TBL] [Abstract][Full Text] [Related]
2. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
Zhang L; Niu H; Ma J; Yuan BY; Chen YH; Zhuang Y; Chen GW; Zeng ZC; Xiang ZL
Mol Cancer; 2019 Jul; 18(1):120. PubMed ID: 31349837
[TBL] [Abstract][Full Text] [Related]
3. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; He J; Zeng HY; Zhu XD
Oncologist; 2011; 16(7):1028-39. PubMed ID: 21665914
[TBL] [Abstract][Full Text] [Related]
4. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
[TBL] [Abstract][Full Text] [Related]
6. Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma.
Bharali D; Jebur HB; Baishya D; Kumar S; Sarma MP; Masroor M; Akhter J; Husain SA; Kar P
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2561-2568. PubMed ID: 30256056
[TBL] [Abstract][Full Text] [Related]
7. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
10. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression.
Wang Y; Tai Q; Zhang J; Kang J; Gao F; Zhong F; Cai L; Fang F; Gao Y
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):243-253. PubMed ID: 30805592
[TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
17. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
Du X; Fan W; Chen Y
Gene; 2018 May; 657():30-38. PubMed ID: 29505836
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C
Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
Li G; Yang F; Xu H; Yue Z; Fang X; Liu J
Biomed Pharmacother; 2015 Jul; 73():154-9. PubMed ID: 26211597
[TBL] [Abstract][Full Text] [Related]
20. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
